In a milestone decision at the 76th World Health Assembly (WHA76), a resolution aimed at addressing health challenges faced by indigenous peoples worldwide has been approved. With it, the Director-General of the WHO has been directed to develop a comprehensive global action plan dedicated to improving their health outcomes by 2026. Indigenous peoples, encompassing a […] Continue reading ->
The World Health Assembly has re-elected India to serve as WHO’s external auditor for the next four years – but there was a steep price tag attached to this year’s appointment. WHO will pay nearly $1 million for India’s services over the coming three-year term of 2024-2027  – amounting to US$ 2.268 million, according to […] Continue reading ->
When Elvis Ndikum Achiri, a long-time veteran of tobacco control campaigns, began collecting data on air pollution in his community in Cameroon, he was surprised to discover how many people around him, both young and old, suffered from related illnesses even though they had never smoked – including a beloved high school teacher who had […] Continue reading ->
An impossibly long list of member states lined up to address universal health coverage (UHC) and non-communicable diseases (NCDs) at the World Health Assembly on Thursday afternoon, indicating the centrality of these issues for countries. There was near-universal support for primary health services to be the backbone of UHC, with disease prevention as the other […] Continue reading ->
The World Health Assembly opened its annual meeting of member states Sunday on a celebratory note marking the 75th anniversary of the World Health Organization’s foundation in 1948. Eradicating smallpox, eliminating polio in most countries worldwide, and dramatic reductions in deaths from once-deadly childhood diseases preventable by clean water, basic medicines and vaccines are among […] Continue reading ->
The US Food and Drug Administration (FDA) has approved the first-ever vaccine for respiratory syncytial virus (RSV). The single-shot vaccine intended for use in adults aged 60 or older represents the culmination of six decades of research to protect the world from RSV. With the green light from the FDA on Wednesday, GSK’s Arexvy vaccine […] Continue reading ->